254 related articles for article (PubMed ID: 29524717)
1. Clinical Characteristics and Prognostic Analysis of Glioma in Human Immunodeficiency Virus-Infected Patients.
Wang T; Gao T; Niu X; Xing X; Yang Y; Liu Y; Mao Q
World Neurosurg; 2018 Jun; 114():e218-e223. PubMed ID: 29524717
[TBL] [Abstract][Full Text] [Related]
2. An Integrative Survival Analysis with Identification of Prognostic Factors in the Patients with Coexisting Glioma and Intracranial Aneurysm.
Niu X; Wang T; Li J; Niu L; Yang Y; Wang X; Liu Y; Mao Q
World Neurosurg; 2018 Mar; 111():e592-e600. PubMed ID: 29288842
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Factors for Survival Outcome of High-Grade Multicentric Glioma.
Wang T; Niu X; Gao T; Zhao L; Li J; Gan Y; Liu Y; Mao Q
World Neurosurg; 2018 Apr; 112():e269-e277. PubMed ID: 29337167
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of prognostic factors on survival in patients with low grade glioma.
Durmaz R; Vural M; Işildi E; Coşan E; Ozkara E; Bal C; Ciftçi E; Arslantaş A; Atasoy MA
Turk Neurosurg; 2008 Oct; 18(4):336-44. PubMed ID: 19107679
[TBL] [Abstract][Full Text] [Related]
5. Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy.
Park CK; Lee SH; Han JH; Kim CY; Kim DW; Paek SH; Kim DG; Heo DS; Kim IH; Jung HW
BMC Cancer; 2009 Dec; 9():450. PubMed ID: 20017960
[TBL] [Abstract][Full Text] [Related]
6. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.
Palmer JD; Siglin J; Yamoah K; Dan T; Champ CE; Bar-Ad V; Werner-Wasik M; Evans JJ; Kim L; Glass J; Farrell C; Andrews DW; Shi W
J Neurooncol; 2015 Sep; 124(2):215-21. PubMed ID: 26024653
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy of malignant gliomas: results from conventional treatment methods and the prospects of advanced techniques.
Rubino G; Sacco P; Cerase A; Volterrani L; Sebaste L; Pepi F; Pirtoli L
Radiol Med; 2004; 107(1-2):128-35. PubMed ID: 15031704
[TBL] [Abstract][Full Text] [Related]
8. [Survival of newly diagnosed malignant glioma patients on combined modality therapy].
Yang QY; Shen D; Sai K; Jiang XB; Ke C; Zhang XH; Mou YG; Chen ZP
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(1):8-10. PubMed ID: 23578444
[TBL] [Abstract][Full Text] [Related]
9. Pleomorphic xanthoastrocytoma: long-term results of surgical treatment and analysis of prognostic factors.
Gallo P; Cecchi PC; Locatelli F; Rizzo P; Ghimenton C; Gerosa M; Pinna G
Br J Neurosurg; 2013 Dec; 27(6):759-64. PubMed ID: 23514331
[TBL] [Abstract][Full Text] [Related]
10. Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates.
Jain R; Narang J; Griffith B; Bagher-Ebadian H; Scarpace L; Mikkelsen T; Littenberg B; Schultz LR
Acad Radiol; 2013 Apr; 20(4):478-85. PubMed ID: 23498990
[TBL] [Abstract][Full Text] [Related]
11. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
[TBL] [Abstract][Full Text] [Related]
12. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients.
Lote K; Egeland T; Hager B; Stenwig B; Skullerud K; Berg-Johnsen J; Storm-Mathisen I; Hirschberg H
J Clin Oncol; 1997 Sep; 15(9):3129-40. PubMed ID: 9294476
[TBL] [Abstract][Full Text] [Related]
13. Clinical features, management and outcomes of high-grade glioma patients in Ramathibodi Hospital.
Chansriwong P; Sirisinha T
J Med Assoc Thai; 2010 Feb; 93 Suppl 2():S68-73. PubMed ID: 21299082
[TBL] [Abstract][Full Text] [Related]
14. [Pattern of care of high-grade gliomas].
Laigle-Donadey F; Sanson M
Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience.
Matsui JK; Allen PK; Perlow HK; Johnson JM; Paulino AC; McAleer MF; Fouladi M; Grosshans DR; Ghia AJ; Li J; Zaky WT; Chintagumpala MM; Palmer JD; McGovern SL
J Neurooncol; 2023 Jul; 163(3):717-726. PubMed ID: 37440097
[TBL] [Abstract][Full Text] [Related]
16. Lower expression of Bax predicts poor clinical outcome in patients with glioma after curative resection and radiotherapy/chemotherapy.
Wang PG; Li YT; Pan Y; Gao ZZ; Guan XW; Jia L; Liu FT
J Neurooncol; 2019 Jan; 141(1):71-81. PubMed ID: 30446901
[TBL] [Abstract][Full Text] [Related]
17. Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.
Yang P; Wang Y; Peng X; You G; Zhang W; Yan W; Bao Z; Wang Y; Qiu X; Jiang T
J Neurooncol; 2013 Jun; 113(2):259-66. PubMed ID: 23483435
[TBL] [Abstract][Full Text] [Related]
18. Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
Koo T; Lim DH; Seol HJ; Dho YS; Kim IH; Chang JH; Lee J; Jung TY; Gwak HS; Cho KH; Hong CK; Lee IJ; Kim E; Kim JH; Hong YK; Jang HS; Kim CY; Kim IA; Kim SH; Kim YI; Kim EY; Kim WC; Hong S
J Neurooncol; 2018 Nov; 140(2):445-455. PubMed ID: 30097825
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Adjuvant Radiation Therapy Alone and Chemotherapy Alone in Surgically Resected Low-Grade Gliomas: Survival Analyses of 2253 Cases from the National Cancer Data Base.
Wu J; Neale N; Huang Y; Bai HX; Li X; Zhang Z; Karakousis G; Huang R; Zhang PJ; Tang L; Xiao B; Yang L
World Neurosurg; 2018 Apr; 112():e812-e822. PubMed ID: 29409888
[TBL] [Abstract][Full Text] [Related]
20. Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma.
Haque W; Verma V; Butler EB; Teh BS
J Neurooncol; 2017 Jun; 133(2):369-375. PubMed ID: 28432588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]